Prevalence ofRET/PTCRearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity
Open Access
- 1 September 2006
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 91 (9) , 3603-3610
- https://doi.org/10.1210/jc.2006-1006
Abstract
Context:RET/PTC rearrangements have been reported in papillary thyroid carcinomas with variable frequency in studies that used different detection methods. Objective: Our objective was to determine the role of different detection methods and tumor genetic heterogeneity on RET/PTC detection. Design: Sixty-five papillary carcinomas were analyzed for RET/PTC1 and RET/PTC3 using five detection methods: standard-sensitivity RT-PCR, high-sensitivity RT-PCR, real-time LightCycler RT-PCR, Southern blot analysis, and fluorescence in situ hybridization. Results:RET/PTC rearrangements were detected by standard-sensitivity RT-PCR in 14 tumors. High-sensitivity RT-PCR detected RET/PTC in all of these and in 12 additional cases, where the levels of expression corresponded to one to five positive cells. Real-time LightCycler RT-PCR detected RET/PTC in 12 and Southern blot analysis in 11 tumors. By fluorescence in situ hybridization, 14 tumors were positive, including nine cases with 50–86% positive cells and five cases with 17–35% positive cells. Overall, nine (14%) tumors harbored clonal rearrangements, which were present in the majority of tumor cells and detected by all five methods. Five (8%) cases had subclonal rearrangements present in a smaller portion of tumor cells and detected by most methods. Twelve (18%) tumors had nonclonal RET/PTC that were detected only by high-sensitivity RT-PCR. No other mutations were found in tumors harboring clonal RET/PTC, whereas 60% of tumors with subclonal and 42% of tumors with nonclonal RET/PTC harbored additional mutations. Conclusions: Our data suggest that broad variability in the reported prevalence of RET/PTC rearrangement is at least in part a result of the use of different detection methods and tumor genetic heterogeneity.Keywords
This publication has 24 references indexed in Scilit:
- Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinomaLaboratory Investigation, 2004
- Heterogeneity in the Distribution ofRET/PTCRearrangements within Individual Post-Chernobyl Papillary Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2004
- RET Oncogene Activation in Papillary Thyroid CarcinomaAdvances in Anatomic Pathology, 2001
- Distinct frequency ofret rearrangements in papillary thyroid carcinomas of children and adults from BelarusInternational Journal of Cancer, 1999
- High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiationOncogene, 1997
- ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?Journal of Clinical Endocrinology & Metabolism, 1996
- Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumoursBritish Journal of Cancer, 1993
- Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.Journal of Clinical Investigation, 1992
- PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasPublished by Elsevier ,1990
- A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastasesNature, 1987